Inventor
Jean Quancard
Inventor
Huningue, FR
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes25%
C07CAcyclic or carbocyclic compounds4%
C07KPeptides4%
PatentTitleYear
10,442,808Pyrazolo pyrimidine derivatives and their use as MALT1 inhbitors20199,815,842'Pyrazolo pyrimidine derivatives and their use as MALT1 inhibitors'20179,815,819'Complement pathway modulators and uses thereof'20179,487,483'Complement pathway modulators and uses thereof'20169,468,661'Pyrrolidine derivatives and their use as complement pathway modulators'20169,464,081'Pyrrolidine derivatives and their use as complement pathway modulators'20169,085,555'Complement pathway modulators and uses thereof'20158,791,100'Aryl benzylamine compounds'2014Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2014–2019Patents assigned to NOVARTIS AG (8)· patent assignee history
2014–2017Patents assigned to QUANCARD JEAN (3)· patent assignee history
2014Patents assigned to ANGST DANIELA (1)· patent assignee history
2014Based in Basel, CH· patent location history
2015–2017Patents assigned to SIMIC OLIVER (2)· patent assignee history
2015Patents assigned to ALTMANN EVA (1)· patent assignee history
2015–2019Based in Huningue, FR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 8 | 2014–2019 |
| QUANCARD JEANself | 3 | 2014–2017 |
| SIMIC OLIVER | 2 | 2015–2017 |
| ALTMANN EVA | 1 | 2015 |
| ANGST DANIELA | 1 | 2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Huningue, FR | 7 | 2015–2019 |
| Basel, CH | 1 | 2014 |